Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase II study of HJ787 ointment in plaque psoriasis
CTR20263821Phase 2Active
- Sponsor
- Huajian Future
- Start
- Oct 2026
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of HJ787 in plaque psoriasis, sponsored by Huajian Future. Started Oct 2026; status: active.
02
Drugs
HJ787
03
Conditions
plaque psoriasis
Beyond the preview
Go deeper on CTR20263821.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20263821.